1. Home
    2. Current page
    Blue Goat CyberBlue Goat Cyber(844) 939-4628Call
    FDA Deficiency Letter Response

    FDA Cybersecurity Deficiency Letter? We Respond

    Answer the FDA's cybersecurity questions with device-specific evidence. Fixed-fee quote after scoping.

    Answer the FDA's actual cybersecurity questions with device-specific evidence. We review the letter, existing records, and patient-safety context before scoping document updates or testing. Your regulatory team reviews and submits the response. Fixed-fee quote within 24 hours of the scoping call.

    FDA cybersecurity deficiency letter response services for medical device manufacturers.

    Book my free 30-min discovery call
    Request a written scope instead
    • Fixed fee after scoping
    • Defined deliverables
    • Deficiency responses covered

    275+ FDA submissions supported, zero cybersecurity rejections.

    Check the deadline in your actual FDA correspondence with your regulatory team. Share the letter and available evidence so we can agree achievable response milestones.

    Last updated October 26, 2026

    Free 30-min discovery call

    Tell us about your FDA letter

    Discuss the actual letter, deadline, existing evidence, and available test access. We agree confidential handling before you transfer device material. The scoping call identifies the questions and work needed for a fixed-fee response proposal.

    • Check calendar availability
    • 30 minutes, your local time
    • Quote within 24 hours of the scoping call
    1. 1Pick a time
    2. →
    3. 2Confirm your email. That's it.
    Open calendar in a new tab

    Mutual NDA signed before the call. No pitch, a senior engineer will tell you straight if you don't need us.

    Request a written scope

    Send your device summary. A senior engineer will reply within one business day to discuss the work and inputs needed for a fixed-fee proposal. No booking required.

    Not the one who books the call? Send them our one-pager (PDF)

    About this engagement

    Answer the FDA's actual cybersecurity questions with device-specific evidence. We review the letter, existing records, and patient-safety context before scoping document updates or testing. Your regulatory team reviews and submits the response. Fixed-fee quote within 24 hours of the scoping call.

    FDA cybersecurity deficiency letter response services for medical device manufacturers.

    Included in your agreed scope

    • Point-by-point response to every cybersecurity finding
    • Document updates identified by the letter review; VEX optional
    • Security testing where agreed evidence gaps require it
    • References to applicable requirements and supporting evidence
    • Cover letter + redline summary for your regulatory team
    • Cybersecurity follow-up responses covered
    • 30 days or less from kickoff once letter, documents, and test access are in hand; engineering fixes, retests, and regulatory review can add time

    Trusted by medical device teams worldwide

    Intuitive Surgical logo
    bioMérieux logo
    Inogen logo
    Natera logo
    Velico Medical logo
    Medivis logo
    Spiro Robotics logo
    Nova Biomedical logo
    VitalConnect logo
    Lifecycle scope

    What's in your deficiency response package

    The proposal identifies included deliverables, exclusions, manufacturer inputs, and review responsibilities for this engagement.

    01

    Every finding mapped & answered

    Each cybersecurity question gets a numbered technical response with supporting evidence and page references. Cite the applicable law or guidance without assuming every concern is a Section 524B issue. The FDA decides whether the response addresses its concern.

    02

    Letter-specific response plan

    Your regulatory team confirms the correspondence type, procedural status, and deadline. We agree technical work and dependencies against that actual letter.

    03

    Scoped SBOM and vulnerability updates

    Update the inventory or component assessment when the letter calls for it. SPDX is the default; CycloneDX can be agreed. VEX is optional communication of manufacturer-reviewed vulnerability assessments.

    04

    Testing based on the evidence gap

    The letter and existing test records determine whether explanation, new testing, or retests are needed. Agree interfaces, build versions, access, exclusions, and engineering dependencies before testing.

    05

    Structured cover letter

    Each item follows the same order: concern, response, evidence, and location in the submission.

    06

    Fixed fee, revisions included

    One quote covers the response and any follow-up exchanges until the cybersecurity file is closed. No retest invoices.

    Illustrative security checks

    Evidence areas to review against your FDA letter

    Review these evidence areas against the actual letter. The letter, existing records, and testing needs determine the response scope.

    SBOM and component vulnerability concerns

    Review the inventory and component assessments against the actual concern. SPDX is our default format. VEX is optional; its absence alone does not establish a deficiency. Updates are scoped to the evidence needed.

    Threat model gaps

    Check system coverage, data flow diagrams, trust boundaries, and threat-to-control traceability. We scope the threat model and Threat Table updates needed. Security architecture views are separate deliverables.

    Insufficient pen test evidence

    Identify the missing test evidence, affected interfaces, and device build. New testing or retests depend on the concern and existing coverage; neither a full rebuild nor a targeted retest is assumed.

    Section 524B traceability gaps

    Missing traceability between Section 524B(b)(1)-(3) requirements and submission artifacts. We deliver a refreshed matrix that points each requirement to its evidence.

    SPDF / secure development process gaps

    Check whether secure development records describe the manufacturer's actual processes and evidence. Documentation updates and QMS implementation work are scoped separately; your quality team approves its processes.

    Postmarket plan gaps

    Reviewer wants a credible coordinated vulnerability disclosure (CVD) process, SBOM monitoring plan, and patch cadence. We document what you'll actually do.

    What happens after you book the call

    1. 1Scoping

      Review your letter and evidence

      Discuss architecture, available records, access, responsibilities, and target dates. Agree confidential handling before transferring device material.

    2. 2Proposal

      Agree deliverables, fee, and dates

      The proposal identifies included work, exclusions, manufacturer inputs, and delivery milestones. The 24-hour quote turnaround is separate from delivery, remediation, and review time.

    3. 3Agreed dates

      Prepare the response evidence

      Update the artifacts and testing identified by the letter review. Deliver a point-by-point response with evidence references for your regulatory team to review and submit. The FDA decides the outcome.

    "Their report helped us achieve FDA clearance without any additional questions. It was a truly seamless experience."
    Anna Norman, VP of Product, InfoBionic.Ai
    "Blue Goat's niche expertise in FDA-facing cybersecurity made all the difference. Their reports were built with the FDA's expectations in mind; it gave us confidence that we were submitting exactly what reviewers want to see."
    Scott Odland, Solutions Architect, Rhaeos
    "The organized documentation, perfectly formatted for eSTAR, saves us countless hours. Their expertise and smooth process mean we can focus on our product, not the paperwork."
    Amy Lynn, Chief Compliance Officer, Medivis

    Blue Goat Cyber vs. the alternatives

    What you actually get versus a generic regulatory consultant or re-spinning the cybersecurity attachment in-house against the 180-day clock.

    Cyber-deficiency-specific experience

    Blue Goat
    Letter review and scoped technical evidence updates
    Generic regulatory consultant
    Treats cyber as a regulatory writing task
    In-house
    First time under deadline pressure

    Response dates based on the actual letter

    Blue Goat
    Dates agreed after letter and evidence review
    Generic regulatory consultant
    Hourly, drifts with scope
    In-house
    Competes with engineering work

    Maps response point-by-point to the letter

    Blue Goat
    Mirrors reviewer's exact ordering
    Generic regulatory consultant
    General rewrite, gaps remain
    In-house
    Built from scratch, easy to miss items

    eSTAR-attachable cover letter + evidence

    Blue Goat
    Evidence mapped for manufacturer review and assembly
    Generic regulatory consultant
    Word docs that need reformatting
    In-house
    Reformatted each time

    Pricing model

    Blue Goat
    Fixed fee, revisions included
    Generic regulatory consultant
    Hourly + change orders
    In-house
    Hidden internal cost
    CapabilityBlue Goat CyberGeneric regulatory consultantIn-house
    Cyber-deficiency-specific experienceLetter review and scoped technical evidence updatesTreats cyber as a regulatory writing taskFirst time under deadline pressure
    Response dates based on the actual letterDates agreed after letter and evidence reviewHourly, drifts with scopeCompetes with engineering work
    Maps response point-by-point to the letterMirrors reviewer's exact orderingGeneral rewrite, gaps remainBuilt from scratch, easy to miss items
    eSTAR-attachable cover letter + evidenceEvidence mapped for manufacturer review and assemblyWord docs that need reformattingReformatted each time
    Pricing modelFixed fee, revisions includedHourly + change ordersHidden internal cost

    Support matched to your scope

    If the FDA raises a cybersecurity question, we answer it at no extra cost until the cybersecurity portion is closed.

    Mutual NDA before the call

    We sign a mutual NDA before the initial call so you can share device details, architecture, and FDA correspondence freely.

    Fixed-fee quote within 24 hours of the call

    The quote identifies deliverables, assumptions, and dates. Quote turnaround is separate from the time needed to deliver the work.

    Senior US engineers, fixed fee

    Senior-led cybersecurity work within the agreed scope. Your team reviews the evidence and owns risk, release, and submission decisions.

    Common questions

    Do you sign an NDA before we share the FDA letter?

    Yes. We complete a mutual NDA before the initial 30-minute call. You can share the FDA letter, device architecture, and submission artifacts freely once it's in place.

    AINN vs deficiency letter vs additional information request, does it matter?

    Yes. Confirm the correspondence type, procedural status, and deadline with your regulatory team. Additional Information (AI) does not mean artificial intelligence. We map the actual cybersecurity questions to explanations, document updates, analysis, or testing. Not every letter requires the same work.

    How fast can you turn this around?

    We deliver the cybersecurity response package in 30 days or less from kickoff, once we have the FDA letter, existing documentation, and test access. Engineering fixes on your side, retests, and your regulatory review can add time, so we agree dates against your actual FDA deadline before work starts.

    What is the smallest first step?

    The free 30-minute call, under mutual NDA. A senior specialist reads the actual letter with you, flags which concerns need new evidence versus rewording, and you get a written scope and fixed-fee quote within 24 hours. You decide after that; there is no commitment on the call.

    What does the fixed fee cover?

    The proposal lists the point-by-point technical response, evidence references, and any document updates or testing needed. SPDF, SBOM, threat model, Threat Table, architecture views, and testing work are included only when identified in that scope. VEX is optional. Engineering fixes, risk acceptance, and submission stay with the manufacturer.

    What if the FDA comes back with follow-up questions?

    If the FDA raises a cybersecurity question, we answer it at no extra cost until the cybersecurity portion is closed. Your regulatory team reviews and submits the response. The FDA makes the regulatory decision.

    Can our team write the response with your guidance?

    Yes. We can scope technical review and response support or preparation of the agreed documents. Your regulatory team retains review and submission responsibility.

    Christian Espinosa, Founder & CEO of Blue Goat Cyber

    Who you're talking to

    Christian Espinosa, Founder & CEO

    MBA, CISSP · U.S. Air Force Academy graduate · 30+ years in cybersecurity

    Christian leads the senior medical device cybersecurity team behind 275+ FDA submissions supported, zero cybersecurity rejections. Author of three books including Medical Device Cybersecurity: An In-Depth Guide.

    LinkedInFull bio

    Got an FDA cybersecurity deficiency letter?

    30-minute call with a senior medical device cybersecurity expert. Mutual NDA signed before the call. Fixed-fee quote within 24 hours of the scoping call. Response delivery dates are agreed separately.

    Pick a time that worksCall (844) 939-4628
    Replies in 1 business day/Mutual NDA first/US-based senior engineer/No sales pitch
    See the full deficiency response service →

    Blue Goat Cyber

    Scottsdale, Arizona, USA · (844) 939-4628

    • Privacy Policy
    • Terms
    • Contact
    • Vulnerability Disclosure

    © 2026 Blue Goat Cyber. All rights reserved.

    CallBook free call